2002
DOI: 10.1208/ps040102
|View full text |Cite
|
Sign up to set email alerts
|

Ocular tolerance of absorption enhancers in ophthalmic preparations

Abstract: The use of absorption promoters is a way to improve the bioavailability and therapeutic response of topically applied ophthalmic drugs. The ocular tolerance of 9 potential absorption promoters was investigated as well as the influence of the enhancers' concentration on the ocular tolerance. The substances tested were instillated repetitively (4 times per day, during 3 days, and once just before examination) as aqueous solutions onto rabbit corneas. Fluorescein dyeing enabled us to specifically mark corneal dam… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
26
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 46 publications
(28 citation statements)
references
References 19 publications
2
26
0
Order By: Relevance
“…Previous studies with Tween 20 have also noted a similar response in increasing very dilute concentrations: doubling the concentration from 0.5% to 1% had little effect on the corneal surface epithelium (27). This response was also reflected in the experiment with no significant damage seen in the lens tissue between 0% and 1% Tween 20 treatments.…”
supporting
confidence: 75%
“…Previous studies with Tween 20 have also noted a similar response in increasing very dilute concentrations: doubling the concentration from 0.5% to 1% had little effect on the corneal surface epithelium (27). This response was also reflected in the experiment with no significant damage seen in the lens tissue between 0% and 1% Tween 20 treatments.…”
supporting
confidence: 75%
“…Good ocular tolerability and no signs of ocular damage of the rabbit corneas have been reported after application of 0.5% (w/v) CH solution onto rabbit eyes. 81 A possible reason is the inclusion of CH molecules in the bilayer membrane of the prepared niosomes, which is likely to reduce the direct contact of CH molecules with ocular surface.…”
Section: Resultsmentioning
confidence: 99%
“…5,6 Unfortunately, excipients enhancing transcorneal transport have a significant potential to induce ocular toxicity, likely because they affect the integrity of interepithelial tight junctions and/or epithelial membrane function. [7][8][9][10] In particular, the most effective penetration enhancer identified for scFv, 5,6 sodium caprate, is toxic to the cornea 11 and is not approved for topical use by the FDA.…”
mentioning
confidence: 99%